Literature DB >> 22428929

A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program.

Mi Jin Park1, Kui Son Choi, You Kyoung Lee, Jae Kwan Jun, Hoo-Yeon Lee.   

Abstract

OBJECTIVE: The National Cancer Screening Program (NCSP) has since 2004 provided annual colorectal cancer screening using the fecal immunochemical test (FIT) for individuals aged 50 years or older. The aim of this study was to examine the positivity and detection rates of the FIT and to compare the detection rates of the qualitative and quantitative FITs in participants in the 2009 NCSP.
METHODS: We analyzed positivity and detection rates according to FIT type (qualitative and quantitative). We used a multinomial logistic regression to analyze the odds ratio of "benign" or "suspicious cancer and cancer" compared to "normal," adjusted for gender, age, health insurance type, region of residence, hospital type, and FIT type.
RESULTS: Of the 1,181,904 participants, 72.8% received a qualitative and 27.2% a quantitative FIT. The positivity rates were 8.1% for the qualitative and 2.5% for the quantitative FIT. The detection rate was 5.2% for the qualitative and 14.4% for the quantitative FIT. The odds ratio of a "suspicious cancer and cancer" versus a "normal" result was 2.73 (95% CI = 2.22-3.35) for the quantitative compared to qualitative FIT, after adjustment.
CONCLUSIONS: The positivity rate of the qualitative FIT was around three times higher than that of the quantitative FIT. However, the odds ratio for detection of "suspicious cancer and cancer" versus "normal" of the quantitative FIT was about three times higher than that of the qualitative FIT. These findings suggest that quality control may be important, particularly for the qualitative FIT.

Entities:  

Mesh:

Year:  2012        PMID: 22428929     DOI: 10.3109/00365521.2012.668930

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer.

Authors:  Yvette N Lamb; Sohita Dhillon
Journal:  Mol Diagn Ther       Date:  2017-04       Impact factor: 4.074

2.  One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.

Authors:  Le Wang; Hongda Chen; Yunfeng Zhu; Ming Lu; Youqing Wang; Xinmin Chen; Weihua Ma; Lingbin Du; Wanqing Chen
Journal:  BMJ Open       Date:  2022-05-19       Impact factor: 3.006

Review 3.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

4.  Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.

Authors:  Jae Myung Cha; Mina Suh; Min Seob Kwak; Na Young Sung; Kui Son Choi; Boyoung Park; Jae Kwan Jun; Sang-Hyun Hwang; Do-Hoon Lee; Byung Chang Kim; You Kyoung Lee; Dong Soo Han
Journal:  Am J Gastroenterol       Date:  2018-03-06       Impact factor: 10.864

5.  Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death.

Authors:  Li-Sheng Chen; Amy Ming-Fang Yen; Callum G Fraser; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; Po-En Wang; Sheng-Che Lin; Chao-Sheng Liao; Yi-Chia Lee; Han-Mo Chiu; Hsiu-Hsi Chen
Journal:  BMJ Open       Date:  2013-11-07       Impact factor: 2.692

6.  Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea.

Authors:  Jae Kwan Jun; Na Young Sung; Seung Hoon Song; Seri Hong; Mi Ae Jang; Junghan Song; Jeong Ho Kim; Won Ki Min; You Kyoung Lee
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

7.  Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies.

Authors:  Gladys N Honein-Abouhaidar; Monika Kastner; Vincent Vuong; Laure Perrier; Linda Rabeneck; Jill Tinmouth; Sharon Straus; Nancy N Baxter
Journal:  BMJ Open       Date:  2014-02-27       Impact factor: 2.692

8.  Validity of fecal occult blood test in the national cancer screening program, Korea.

Authors:  Aesun Shin; Kui Son Choi; Jae Kwan Jun; Dai Keun Noh; Mina Suh; Kyu-Won Jung; Byung Chang Kim; Jae Hwan Oh; Eun-Cheol Park
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Performance of the Fecal Immunochemical Test for Colorectal Cancer Screening Using Different Stool-Collection Devices: Preliminary Results from a Randomized Controlled Trial.

Authors:  Hye Young Shin; Mina Suh; Hyung Won Baik; Kui Son Choi; Boyoung Park; Jae Kwan Jun; Sang-Hyun Hwang; Byung Chang Kim; Chan Wha Lee; Jae Hwan Oh; You Kyoung Lee; Dong Soo Han; Do-Hoon Lee
Journal:  Gut Liver       Date:  2016-11-15       Impact factor: 4.519

10.  Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea.

Authors:  Dae Ho Kim; Jae Myung Cha; Min Seob Kwak; Jin Young Yoon; Young-Hak Cho; Jung Won Jeon; Hyun Phil Shin; Kwang Ro Joo; Joung Il Lee
Journal:  Gut Liver       Date:  2018-03-15       Impact factor: 4.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.